WHERRY; E. John

Patent Applications and Registrations

Patent applications and USPTO patent grants for WHERRY; E. John.The latest application filed is for "modulation of expression of genes related to t cell exhaustion".

Company Profile

4.5.10

WHERRY; E. John - Havertown PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Modulation Of Expression Of Genes Related To T Cell Exhaustion App 20220211759 - WHERRY; E. John ; et al.	2022-07-07
Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (PD-1) pathway Grant 11,359,013 - Freeman , et al. June 14, 2	2022-06-14
T-cell Exhaustion State-specific Gene Expression Regulators And Uses Thereof App 20210309965 - Haining; William N. ; et al.	2021-10-07
Identifying Epigenetic And Transcriptional Targets To Prevent And Reverse T Cell Exhaustion App 20210071139 - WHERRY; E. John ; et al.	2021-03-11
Methods and Compositions for Treating Diseases Associated with Exhausted T Cells App 20210033595 - Wherry; E. John ; et al.	2021-02-04
Compositions And Methods For The Treatment Of Infections And Tumors App 20200223926 - Ahmed; Rafi ; et al.	2020-07-16
Methods And Compositions For The Treatment Of Persistent Infections And Cancer By Inhibiting The Programmed Cell Death 1 (pd-1) App 20190309065 - Freeman; Gordon ; et al.	2019-10-10
Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (PD-1) pathway Grant 10,370,446 - Freeman , et al.	2019-08-06
Compositions And Methods For The Treatment Of Infections And Tumors App 20190031758 - Ahmed; Rafi ; et al.	2019-01-31
Methods And Compositions For The Treatment Of Persistent Infections And Cancer By Inhibiting The Programmed Cell Death 1 (pd-1) Pathway App 20160362492 - Freeman; Gordon ; et al.	2016-12-15
Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (PD-1) pathway Grant 9,457,080 - Freeman , et al. October 4, 2	2016-10-04
Methods And Compositions For The Treatment Of Persistent Infections And Cancer By Inhibiting The Programmed Cell Death 1 (pd-1) Pathway App 20140178370 - Freeman; Gordon ; et al.	2014-06-26
Methods and compositions for the treatment of persistent infections Grant 8,652,465 - Freeman , et al. February 18, 2	2014-02-18
Methods and compositions for the treatment of persistent infections App 20070122378 - Freeman; Gordon ; et al.	2007-05-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.